Trimethylammonium

Trimethylammonium

SCHEMBL20239685

C=C(C)C(=O)NCCCO[PH](=O)O.CN(C)C.Cl

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Trimethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.31
MMP8 known ✓ P22894 1/20 0.30
ALDH1A1 P00352 1/20 0.33
KDM4E B2RXH2 1/20 0.31
TSHR P16473 1/20 0.30
MMP9 P14780 1/20 0.30
MMP14 P50281 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL29098767 1.00 ALDH1A1 (0.33) ALDH1A1ACHEKDM4ETSHRMMP9
SCHEMBL30678279 0.94 ALDH1A1 (0.36) ALDH1A1ACHEKDM4ETSHRMMP9
SCHEMBL28871197 0.84 THRB (0.32) ALDH1A1
Trimethylammonium SCHEMBL28390914 0.77 FNTA (0.35) ALDH1A1ACHEKDM4ETSHRSMN1; SMN2
Trimethylammonium SCHEMBL28395649 0.77 LPAR3 (0.40) TSHR
SCHEMBL24496157 0.75 ALDH1A1 (0.41) ALDH1A1ACHEKDM4ETSHRMMP9
Trimethylammonium SCHEMBL27905567 0.74 PAOX (0.46) KDM4E
Trimethylammonium SCHEMBL27652101 0.74 PAOX (0.46) KDM4E
SCHEMBL5528349 0.73 THRB (0.41) ALDH1A1ACHEKDM4ETSHRMMP9
SCHEMBL5413785 0.73 ALDH1A1 (0.40) ALDH1A1ACHEKDM4ETSHRMMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11905491-B2 Post CMP cleaning compositions ENTEGRIS, INC. (US) 2024-02-20 US claimed
EP-4225882-A1 POST CMP CLEANING COMPOSITIONS Entegris, Inc. (US) 2023-08-16 EP claimed
CN-116457447-A POST chemical mechanical polishing (POST CMP) cleaning compositions 恩特格里斯公司 2023-07-18 CN claimed
US-11905491-B2 Post CMP cleaning compositions ENTEGRIS, INC. (US) 2024-02-20 US disclosed
CN-110088881-B Composition and method for removing residues from a chemical mechanical planarization substrate CMC材料股份有限公司 2023-09-26 CN disclosed
EP-4225882-A1 POST CMP CLEANING COMPOSITIONS Entegris, Inc. (US) 2023-08-16 EP disclosed
CN-116457447-A POST chemical mechanical polishing (POST CMP) cleaning compositions 恩特格里斯公司 2023-07-18 CN disclosed
US-20220395865-A1 COMPOSITIONS AND METHODS FOR REDUCING INTERACTION BETWEEN ABRASIVE PARTICLES AND A CLEANING BRUSH MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT 2022-12-15 US disclosed
US-11446708-B2 Compositions and methods for reducing interaction between abrasive particles and a cleaning brush ENTEGRIS, INC. (US) 2022-09-20 US disclosed
EP-3555907-A1 COMPOSITION AND METHOD FOR REMOVING RESIDUE FROM CHEMICAL-MECHANICAL PLANARIZATION SUBSTRATE Cabot Microelectronics Corporation (US) 2019-10-23 EP disclosed
WO-2019112751-A1 COMPOSITIONS AND METHODS FOR REDUCING INTERACTION BETWEEN ABRASIVE PARTICLES AND A CLEANING BRUSH ENTEGRIS, INC. (US) 2019-06-13 WO disclosed
US-20190168265-A1 COMPOSITIONS AND METHODS FOR REDUCING INTERACTION BETWEEN ABRASIVE PARTICLES AND A CLEANING BRUSH MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT 2019-06-06 US disclosed
US-20180166273-A1 COMPOSITION AND METHOD FOR REMOVING RESIDUE FROM CHEMICAL-MECHANICAL PLANARIZATION SUBSTRATE CMC MATERIALS LLC 2018-06-14 US disclosed